Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues (NYSE:MED)


Earnings Call Insights: Medifast (MED) Q2 2026

Management View

  • CEO & President Nicholas Johnson said Q2 continued “positive indicators,” highlighting that “revenue has stabilized sequentially over the recent quarters, aided by higher coach productivity, which grew for the third consecutive quarter,” and framed this as a leading indicator

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.



Source link

Dancing With the Stars Reveals Familiar Face Joining Season 35

Internet Says Threw Shots At Papoose At Angie’s BBQ

Leave a Reply

Your email address will not be published. Required fields are marked *